Although most of the attention on Nup98 translocations in cancer has focused on overexpressing the fusion partners, there is increasing evidence that the disruption of endogenous Nup98 and/or Nup96 may contribute to enhanced proliferation that could cooperate with other oncogenic mutations. This evidence concerns the gene NUP98 and cancer.